HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 277-288 of 1,811
Behavioral study icon
CompletedNCT07165509

Neuro-Nutrition to Support Physiological Function and Cognitive Skills in People With Down Syndrome, Autism Spectrum Disorder, and ADHD

Official study title

Neuro-Nutrition as Support for Physiological Function and Cognitive Abilities in Individuals With Down Syndrome, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Mexico City
ADHDBehavioural studyAges 2–35
Countries
Mexico
Sponsor
Elizabeth Guadalupe Ibarra Coronado
Drug study icon
CompletedNCT01709695

Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD

Official study title

Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD): an Functional Magnetic Resonance Imaging(fMRI) Study of Brain Activation Pre and Post Treatment

This study has finished and is no longer accepting participants.

In New York
ADHDMedication studyAges 8–15
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Other study type icon
CompletedNCT04467658

Neurophysiological Marker of ADHD in Children

Official study title

Neurophysiological Marker of Attention Deficit Hyperactivity Disorder in Children

This study has finished and is no longer accepting participants.

In Daegu
ADHDObservational studyAges 7–12
Countries
South Korea
Sponsor
Daegu Catholic University Medical Center
Other study type icon
CompletedNCT02642068

Neuropsychology, Neuroimage and Neurophysiology in Adults With ADHD

Official study title

Neuropsychology, Neuroimage and Neurophysiology in Adults With Attention-Deficit Hyperactivity Disorder: An Endophenotype and Follow-up Study

This study has finished and is no longer accepting participants.

In Taipei
ADHDObservational studyAges 16–30
Countries
Taiwan
Sponsor
National Taiwan University Hospital
Drug study icon
CompletedNCT01835548

NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Bradenton
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Neos Therapeutics, Inc

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.